北美肺功能检测市场报告 - 行业趋势和预测至2031年

北美肺功能测试市场分析与洞察

肺功能测试市场的发展受到呼吸系统疾病患病率不断上升、技术进步和个性化医疗需求不断增长的推动。市场的主要趋势包括即时诊断肺功能测试设备的采用率不断提高、对无线和便携式肺功能测试设备的需求不断增长以及对个性化医疗和精准医疗的关注度不断提高。然而，市场也面临着诸多挑战，例如某些地区肺功能测试设备的可及性有限、肺功能测试设备和耗材成本高、肺功能测试解释和分析复杂以及医疗服务提供者和患者对肺功能测试的认识有限。

Data Bridge Market Research 分析称，北美肺功能测试市场预计将从 2023 年的 15.3 亿美元增至 2031 年的 24.7 亿美元，在 2024 年至 2031 年的预测期内，复合年增长率为 6.1%。

报告指标	细节
预测期	2024 至 2031 年
基准年	2023
历史岁月	2022（可定制为 2016 – 2021）
定量单位	收入（十亿美元）
涵盖的领域	类型（硬件、服务和软件）、患者类型（儿科、成人和老年人）、应用（阻塞性肺病和限制性肺病）、最终用户（医院、专科诊所、诊断实验室、家庭护理环境等）
覆盖国家	美国、加拿大和墨西哥
涵盖的市场参与者	VYAIRE MEDICAL, INC.、Teleflex Incorporated、CAIRE, Inc.、COSMED srl、Schiller AG、PULMONE ADVANCED MEDICAL DEVICE、ndd Medical Technologies、KoKo PFT、ECO MEDICS、Morgan Scientific、Inofab Health、Data Sciences International、IngMar Medical、JK Medical System Pvt. Ltd、MEDLINE、VITALOGRAPH 和 CONTEC MEDICAL SYSTEMS CO, LTD 等

市场定义

肺功能测试 (PFT) 是对肺功能的全面评估，用于诊断和监测呼吸系统疾病，例如慢性阻塞性肺病 (COPD)、哮喘和慢性支气管炎。PFT 的市场定义包括一系列测试，包括用力肺活量 (FVC)、用力呼气量 (FEV1)、FEV1/FVC 比率、最大自主通气量 (MVV) 和弥散能力 (DLCO)。PFT 通常使用肺量计进行，肺量计是一种测量患者吸入和呼出的空气量和流量的设备。

北美肺功能测试市场动态

本节旨在了解市场驱动因素、机遇、限制因素和挑战。下文将详细讨论所有这些内容：

驱动程序

呼吸系统疾病患病率不断上升

呼吸系统疾病的日益流行是全球肺功能测试市场的重要推动力。由于人口老龄化、环境污染物和生活方式改变等因素，慢性阻塞性肺病 (COPD) 和哮喘等疾病变得越来越普遍。随着这些疾病的流行，对准确可靠的诊断工具的需求也随之增加，以管理和监测这些疾病。肺功能测试对于诊断呼吸系统疾病、评估其严重程度和跟踪疾病进展至关重要。随着医疗保健提供者和患者寻求先进的 PFT 技术来改善呼吸系统健康结果并提供有效的管理策略，对定期和精确测试的需求不断增加，推动了市场的发展。

早期发现呼吸系统疾病

早期发现的呼吸系统疾病的增多是全球肺功能测试 (PFT) 市场的主要驱动力。哮喘、慢性阻塞性肺病 (COPD) 和囊性纤维化等呼吸系统疾病的激增推动了对肺功能测试的需求。肺功能测试在早期发现和有效管理呼吸系统疾病方面发挥着至关重要的作用，从而通过及时干预和治疗改善患者的治疗效果和生活质量。

机会

技术飞速进步

创新型肺功能测试设备（尤其是集成人工智能的肺功能测试设备）的开发提高了诊断的准确性和效率，为肺部疾病的诊断提供了更可靠的结果。综合测试系统正变得越来越用户友好和便携，使其能够被更广泛的医疗机构使用。与人工智能和远程医疗等数字医疗技术的结合，可以实现高级诊断准确性和预测分析，以及通过连接的肺功能测试设备进行远程监控，从而扩大这些工具的覆盖范围和影响力。先进的传感器技术（包括高灵敏度和可穿戴传感器）可提供持续监控和实时数据收集，从而实现更精确和及时的干预。

挑战/限制

测试设备成本高

肺功能检测设备价格高昂，限制了小型医疗机构的使用，并阻碍了某些地区的普及，从而阻碍了市场的增长。购买和维护复杂的肺功能检测设备需要大量投资，这对医疗机构（尤其是发展中地区的医疗机构）构成了财务挑战。这一经济障碍限制了肺功能检测技术的广泛采用和使用，影响了整个市场的增长和可及性。解决这些成本挑战对于提高全球肺功能检测的覆盖面和影响力至关重要。

测试结果缺乏标准化和差异性

缺乏统一标准导致设备规格和测试协议存在差异，从而影响不同设备之间测试结果的一致性和可比性。这种差异性使将 PFT 设备与电子健康记录 (EHR) 系统集成变得复杂，使得无缝数据交换和全面的患者记录更加难以实现。如果没有标准化协议，确保来自各种 PFT 设备的数据能够准确高效地集成到 EHR 系统中仍然是一项复杂的任务。

最新动态

2024 年 4 月，Clario 收购 ArtiQ，通过整合先进的 AI 功能增强了其呼吸解决方案产品组合。这一战略举措将 Clario 的专业知识与 ArtiQ 的创新技术相结合，以提高测试质量并加速临床试验中的数据处理。此次收购与 Inofab Health 一起巩固了 Clario 在呼吸护理领域的领导地位，并拓宽了其 AI 驱动的临床解决方案
2023 年 9 月，PulmOne 在中国推出了 MiniBox+，并通过我们的经销商 HTDK 在 2023 年中华医学会胸科学分会 (CTS) 年会上向肺病专家展示。此次介绍受到了与会者的热烈欢迎。查看此次活动的精彩视频集锦
2023 年 5 月，Geratherm Medical AG 被图林根州开发公司 (LEG) 评为“隐形冠军”。这一认可凸显了该公司在医疗技术领域的重要作用及其全球市场地位。董事会成员 Christian Frick 对这一荣誉表示感谢，并指出该公司在医疗诊断、肺功能测量、中风预防和孵化器系统方面的创新，为其未来发展奠定了良好的基础
2023 年 5 月，呼吸诊断领域的领导者 Vitalograph 在 ATS 国际会议上推出了 Vitalograph tremoflo C-100 示波器，扩大了其产品组合。这款创新设备由该公司与 Thorasys 合作开发，可通过简单的潮气呼吸检测小气道损伤，从而增强哮喘和 COPD 的诊断能力。tremoflo C-100 与 Vitalograph Spirotrac 平台集成，可全面了解呼吸健康情况，并支持在各种环境下进行准确、便携的测试
2023 年 4 月，Ingmar Medical 推出了 RespiSim 软件版本 4.3，这是一项重大改进，包括改进了场景导入/导出、减少了模拟延迟并增强了平台稳定性。这些更新显著提高了可用性和性能，使其成为呼吸治疗教育和培训的重要工具。
2022 年 9 月，IngMar Medical 推出了 RespiSim eLearning，这是一个基于订阅的平台，提供价格合理、逼真的通气培训。这款新产品配备了虚拟呼吸机和一套克利夫兰诊所课程，支持混合和远程教育，培养了一个致力于改善患者治疗效果的教育者社区

北美肺功能测试市场范围

北美肺功能测试市场根据类型、患者类型、应用和最终用户分为四个显著的细分市场。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略，并确定您的核心应用领域和目标市场的差异。

类型

硬件
软件
服务

根据服务，北美肺功能测试市场分为硬件、软件和服务。

患者类型

成人
老年
儿科

根据患者类型，北美肺功能测试市场分为成人、老年人和儿童。

应用

阻塞性肺病
限制性肺病

根据应用，北美肺功能测试市场分为阻塞性肺病和限制性肺病。

最终用户

医院
专科诊所
诊断实验室
家庭护理设置
其他的

根据最终用户，北美肺功能测试市场分为医院、专科诊所、诊断实验室、家庭护理环境等。

北美肺功能测试市场区域分析/见解

北美肺功能测试市场根据类型、患者类型、应用和最终用户分为四个显著的部分。

本市场报告涵盖的国家包括美国、加拿大和墨西哥

由于市场参与者的存在以及医疗保健领域的发展和研究不断进步，美国预计将在北美地区占据主导地位。该地区早期的技术采用和成熟的市场促进了对先进解决方案的强劲需求。

报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内市场监管变化。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测各个国家市场情景的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了大型服务公司的存在和可用性以及它们因来自本地和国内参与者的激烈或稀少的竞争而面临的挑战以及销售渠道的影响。

竞争格局和北美肺功能测试市场份额分析

北美肺功能测试市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品批准、产品宽度和广度、应用主导地位以及产品类型生命线曲线。以上提供的数据点仅与公司对市场的关注有关。

该市场的主要市场参与者包括 VYAIRE MEDICAL, INC.、Teleflex Incorporated、CAIRE, Inc.、COSMED srl、Schiller AG、PULMONE ADVANCED MEDICAL DEVICE、ndd Medical Technologies、KoKo PFT、ECO MEDICS、Morgan Scientific、Inofab Health、Data Sciences International、IngMar Medical、JK Medical System Pvt. Ltd、MEDLINE、VITALOGRAPH 和 CONTEC MEDICAL SYSTEMS CO., LTD 等。

SKU-72777

Get online access to the report on the World's First Market Intelligence Cloud

Click on image to enlarge

Interactive Data Analysis Dashboard
Company Analysis Dashboard for high growth potential opportunities
Research Analyst Access for customization & queries
Competitor Analysis with Interactive dashboard
Latest News, Updates & Trend analysis
Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking

Request for Demo

表格列表

TABLE 1 NORTH AMERICA DRUG DELIVERY DEVICES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 2 NORTH AMERICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 3 NORTH AMERICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 4 NORTH AMERICA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 5 NORTH AMERICA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (VOLUME IN UNIT)

TABLE 6 NORTH AMERICA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 7 NORTH AMERICA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 8 NORTH AMERICA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (VOLUME IN UNIT)

TABLE 9 NORTH AMERICA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 10 NORTH AMERICA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 11 NORTH AMERICA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 12 NORTH AMERICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 13 NORTH AMERICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 14 NORTH AMERICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 15 NORTH AMERICA SOFTWARE IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 16 NORTH AMERICA SERVICES IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 17 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 18 NORTH AMERICA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 19 NORTH AMERICA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 20 NORTH AMERICA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 21 NORTH AMERICA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 22 NORTH AMERICA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 23 NORTH AMERICA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 24 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 25 NORTH AMERICA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 26 NORTH AMERICA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 27 NORTH AMERICA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 28 NORTH AMERICA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 29 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 30 NORTH AMERICA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 31 NORTH AMERICA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 32 NORTH AMERICA SPECIALTY CLINICS IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 33 NORTH AMERICA DIAGNOSTICS LABORATORIES IN PULMONARY FUNCTION TESTING, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 34 NORTH AMERICA HOME CARE SETTINGS IN PULMONARY FUNCTION TESTING, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 35 NORTH AMERICA OTHERS IN PULMONARY FUNCTION TESTING, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 36 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)

TABLE 37 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 38 NORTH AMERICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 39 NORTH AMERICA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 40 NORTH AMERICA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 41 NORTH AMERICA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 42 NORTH AMERICA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 43 NORTH AMERICA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 44 NORTH AMERICA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 45 NORTH AMERICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 46 NORTH AMERICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 47 NORTH AMERICA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 48 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 49 NORTH AMERICA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 50 NORTH AMERICA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 51 NORTH AMERICA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 52 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 53 NORTH AMERICA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 54 NORTH AMERICA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 55 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 56 NORTH AMERICA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 57 U.S. PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 58 U.S. HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 59 U.S. PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 60 U.S. PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 61 U.S. PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 62 U.S. MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 63 U.S. ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 64 U.S. NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 65 U.S. HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 66 U.S. HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 67 U.S. RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 68 U.S. PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 69 U.S. ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 70 U.S. GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 71 U.S. PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 72 U.S. PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 73 U.S. OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 74 U.S. RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 75 U.S. PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 76 U.S. HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 77 CANADA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 78 CANADA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 79 CANADA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 80 CANADA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 81 CANADA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 82 CANADA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 83 CANADA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 84 CANADA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 85 CANADA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 86 CANADA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 87 CANADA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 88 CANADA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 89 CANADA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 90 CANADA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 91 CANADA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 92 CANADA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 93 CANADA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 94 CANADA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 95 CANADA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 96 CANADA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 97 MEXICO PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 98 MEXICO HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 99 MEXICO PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 100 MEXICO PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 101 MEXICO PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 102 MEXICO MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 103 MEXICO ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 104 MEXICO NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 105 MEXICO HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 106 MEXICO HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 107 MEXICO RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 108 MEXICO PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 109 MEXICO ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 110 MEXICO GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 111 MEXICO PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 112 MEXICO PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 113 MEXICO OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 114 MEXICO RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 115 MEXICO PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 116 MEXICO HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

图片列表

FIGURE 1 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET: SEGMENTATION

FIGURE 2 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET: DATA TRIANGULATION

FIGURE 3 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET: DROC ANALYSIS

FIGURE 4 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 8 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET: DBMR MARKET POSITION GRID

FIGURE 9 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET: SEGMENTATION

FIGURE 11 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET, BY TYPE

FIGURE 12 EXECUTIVE SUMMARY

FIGURE 13 STRATEGIC DECISIONS

FIGURE 14 INCREASING PREVALENCE OF RESPIRATORY DISEASES IS DRIVING THE GROWTH OF THE NORTH AMERICA PULMONARY FUNCTION TESTING MARKET FROM 2024 TO 2031

FIGURE 15 THE HARDWARE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA PULMONARY FUNCTION TESTING MARKET IN 2024 AND 2031

FIGURE 16 DROC ANALYSIS

FIGURE 17 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET: BY TYPE, 2023

FIGURE 18 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET: BY TYPE, 2024-2031 (USD THOUSAND)

FIGURE 19 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET: BY TYPE, CAGR (2024-2031)

FIGURE 20 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET: BY TYPE, LIFELINE CURVE

FIGURE 21 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET: BY PATIENT TYPE, 2023

FIGURE 22 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET: BY PATIENT TYPE, 2024-2031 (USD THOUSAND)

FIGURE 23 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET: BY PATIENT TYPE, CAGR (2024-2031)

FIGURE 24 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET: BY PATIENT TYPE, LIFELINE CURVE

FIGURE 25 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET: BY APPLICATION 2023

FIGURE 26 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET: BY APPLICATION, 2024-2031 (USD THOUSAND)

FIGURE 27 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET: BY APPLICATION, CAGR (2024-2031)

FIGURE 28 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 29 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET: BY END USER 2023

FIGURE 30 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET: BY END USER, 2024-2031 (USD THOUSAND)

FIGURE 31 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET: END USER, CAGR (2024-2031)

FIGURE 32 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET: END USER, LIFELINE CURVE

FIGURE 33 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET: SNAPSHOT (2023)

FIGURE 34 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET: COMPANY SHARE 2023 (%)

查看详细信息

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

What are the primary segments covered in the North America Pulmonary Function Testing Market report?

The market is segmented based on , By Type (Hardware, Services, and Software), Patient Type (Pediatric, Adult, and Geriatric), Application (Obstructive Lung Disease and Restrictive Lung Disease), End User (Hospital, Specialty Clinics, Diagnostics Laboratories, Home Care Settings, and Others) - Industry Trends and Forecast to 2031. .

What is the current market size of the North America Pulmonary Function Testing Market?

The North America Pulmonary Function Testing Market size was valued at USD 1.53 USD Billion in 2023.

What is the expected growth rate of the North America Pulmonary Function Testing Market?

The North America Pulmonary Function Testing Market is projected to grow at a CAGR of 6.1% during the forecast period of 2024 to 2031.

Which countries are analyzed in the North America Pulmonary Function Testing Market report?

The market report covers data from the U.S., Canada, and Mexico.

Forecast Period	2024 –2031
Market Size (Base Year)	USD 1.53 Billion
Market Size (Forecast Year)	USD 2.47 Billion
CAGR	6.10 %
Major Markets Players	Dummy1 Dummy2 Dummy3 Dummy4 Dummy5 Request For Unlock

北美肺功能测试市场 – 行业趋势和 2031 年预测

北美肺功能测试市场 – 行业趋势和 2031 年预测

North America Pulmonary Function Testing Market

CAGR : 6.10 %

北美肺功能测试市场分析与洞察

北美肺功能测试市场动态

北美肺功能测试市场范围

北美肺功能测试市场区域分析/见解

竞争格局和北美肺功能测试市场份额分析

Get online access to the report on the World's First Market Intelligence Cloud

目录

表格列表

图片列表

研究方法

可定制

Frequently Asked Questions

报告

市场洞察

支持

解决方案

北美肺功能测试市场 – 行业趋势和 2031 年预测

北美肺功能测试市场 – 行业趋势和 2031 年预测

North America Pulmonary Function Testing Market

CAGR : 6.10 %

北美肺功能测试市场分析与洞察

北美肺功能测试市场动态

北美肺功能测试市场范围

北美肺功能测试市场区域分析/见解

竞争格局和北美肺功能测试市场份额分析

Get online access to the report on the World's First Market Intelligence Cloud

目录

表格列表

图片列表

研究方法

可定制

Frequently Asked Questions

浏览相关页面